anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
Bausch Health · conference-presentation

Bausch Health Companies | Results Presentation Deck | 53 slides

53 pages · 5 arc beats · 2 loops

Conference-Presentation Download JSON
Unlock

Bausch Health Companies | Results Presentation Deck | 53 slides

Bausch Health · 2022-05
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
— No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.
—

Deck intelligence map

5
coverage by narrative range · generated from this deck JSON
Narrative range 5 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Attention 1 slides 100% 1/1 slides 100% 1/1 slides · 2 hits
— 0/1 slides
— 0/1 slides
— 0/1 slides
100% 1/1 slides
— 0/1 slides
Need 1 slides 100% 1/1 slides 100% 1/1 slides
— 0/1 slides
— 0/1 slides
— 0/1 slides
100% 1/1 slides 100% 1/1 slides Satisfaction 1 slides 100% 1/1 slides 100% 1/1 slides · 4 hits
— 0/1 slides
— 0/1 slides
— 0/1 slides
100% 1/1 slides
— 0/1 slides
Visualization 1 slides 100% 1/1 slides 100% 1/1 slides · 8 hits
— 0/1 slides
100% 1/1 slides 100% 1/1 slides 100% 1/1 slides
— 0/1 slides
Action 1 slides 100% 1/1 slides 100% 1/1 slides · 4 hits
— 0/1 slides
— 0/1 slides
— 0/1 slides
100% 1/1 slides
— 0/1 slides

Slide inventory

53
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detail
02
other
Open slide detail
03
other
Open slide detail
04
front_matter
Open slide detailBeat · Attention
05
transition
Open slide detail
06
The slide uses a hub-and-spoke diagram to illustrate the corporate restructuring.present_solution
Open slide detailBeat · Visualization
07
The slide uses checkmarks to indicate completed items and empty circles for pending items.plan_implementation
Open slide detailBeat · Action
08
The slide outlines a series of financial maneuvers to de-lever the company.summarize
Open slide detailBeat · Satisfaction
09
transition
Open slide detailBeat · NeedLoop · Cost Of Inaction
10
Includes footnotes regarding non-GAAP measures and segment reporting changes.analyze_data
Open slide detailLoop · Cost Of Inaction
11
Includes footnotes regarding Bausch Health name change and non-GAAP measures.analyze_data
Open slide detailLoop · Cost Of Inaction
12
Includes a line chart for Xifaxan NRx growth and two metric boxes for revenue performance.summarize
Open slide detailLoop · Cost Of Inaction
13
Data presented as bar charts for three products across two metrics (TRx and NRx).analyze_data
Open slide detailLoop · Cost Of Inaction
14
Includes specific product performance metrics (Evolution Index) for Canada, EMEA, and Latin America.analyze_data
Open slide detailLoop · Cost Of Inaction
15
Includes footnotes referencing non-GAAP measures and segment reporting.analyze_data
Open slide detailLoop · Cost Of Inaction
16
Includes specific brand performance metrics and segment revenue composition.summarize
Open slide detailLoop · Cost Of Inaction
17
summarize
Open slide detailLoop · Cost Of Inaction
18
The slide uses a grid of six charts to demonstrate positive performance across contact lenses, Vyzulta, consumer products, Lumify, Stellaris Elite, and internatanalyze_data
Open slide detailLoop · Cost Of Inaction
19
The table includes a footnote regarding non-GAAP measures.analyze_data
Open slide detailLoop · Cost Of Inaction
20
The slide includes detailed footnotes regarding non-GAAP measures, share counts, and specific exclusions.analyze_data
Open slide detail
21
The slide highlights the difference between GAAP operating cash flow and adjusted non-GAAP cash flow, specifically noting the impact of legacy legal settlementsanalyze_data
Open slide detail
22
Includes detailed footnotes regarding debt composition and non-GAAP adjustments.analyze_data
Open slide detail
23
The slide uses a numbered list to highlight five key financial achievements and strategic goals.summarize
Open slide detail
24
The slide uses a before-and-after comparison to highlight the impact of a corporate action (B&L IPO) on debt structure.analyze_data
Open slide detailLoop · Before After
25
The chart shows mandatory amortization payments from 2022-2026 and a large bullet maturity in 2027.analyze_data
Open slide detailLoop · Before After
26
transition
Open slide detail
27
The slide uses a waterfall-bridge structure to explain the delta between initial and updated guidance figures.show_valuation_bridge
Open slide detail
28
The slide includes a specific callout box on the right for additional key metrics and dis-synergy impact.analyze_data
Open slide detail
29
transition
Open slide detail
30
The slide uses a structured list format to categorize R&D and commercial progress by business unit.summarize
Open slide detail
31
The slide provides a snapshot of late-stage pipeline progress as of 1Q 2022.summarize
Open slide detail
32
The slide uses a matrix-style timeline layout to track four distinct drug development programs.plan_implementation
Open slide detail
33
prioritize
Open slide detail
34
appendix
Open slide detail
35
The slide uses a comparison table to illustrate organizational restructuring.present_framework
Open slide detail
36
The table tracks inventory levels across two distinct periods (Dec 31 to Mar 31) for two consecutive years.analyze_data
Open slide detail
37
The slide compares the debt maturity schedule as of March 31, 2022, against a pro forma scenario involving B+L IPO proceeds and refinancings.analyze_data
Open slide detail
38
The slide provides a clear breakdown of debt obligations over a 6-year period.analyze_data
Open slide detail
39
Includes non-GAAP measures; references constant currency and tax rate calculations.analyze_data
Open slide detail
40
appendix
Open slide detail
41
The table provides a detailed breakdown of adjustments to reconcile GAAP net income to non-GAAP adjusted net income.analyze_data
Open slide detail
42
The slide presents two separate tables for YTD 2022 and YTD 2021, detailing adjustments like amortization, impairments, and restructuring costs.analyze_data
Open slide detail
43
The table provides a bridge from GAAP net loss to non-GAAP Adjusted EBITDA.analyze_data
Open slide detail
44
Includes detailed breakdown of currency impacts, divestitures, and growth percentages by segment.analyze_data
Open slide detail
45
The table includes adjustments for exchange rates, divestitures, and discontinuations to arrive at organic revenue figures.analyze_data
Open slide detail
46
The slide provides a bridge between GAAP operating cash flow and a non-GAAP adjusted metric.analyze_data
Open slide detail
47
The table provides a detailed breakdown of adjustments including impairments, restructuring, debt extinguishment, and other operational costs.analyze_data
Open slide detail
48
appendix
Open slide detail
49
Standard financial reporting appendix slide for Bausch Health.appendix
Open slide detail
50
Standard financial disclosure slide defining non-GAAP metrics used in the presentation.appendix
Open slide detail
51
appendix
Open slide detail
52
Standard financial disclosure slide for non-GAAP reconciliations.summarize
Open slide detail
53
appendix
Open slide detail